je.st
news
Tag: biosciences
Integra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical
2015-07-24 12:31:06| Industrial Newsroom - All News for Today
PLAINSBORO, N.J. Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced that it has completed the acquisition of all of the outstanding shares of TEI Biosciences Inc. and TEI Medical Inc. ("TEI"). "We are enthusiastic about the strategic fit of these two organizations, and the positive impact...
Tags: medical
acquisition
completes
integra
Arcadia Biosciences' Nitrogen Use Efficiency Trait Completes US Food And Drug Administration Early Food Safety Evaluation
2015-06-17 05:26:49| foodingredientsonline Home Page
Arcadia Biosciences, Inc., an agricultural technology company, announced recently that the US Food and Drug Administration (FDA) has completed the Early Food Safety Evaluation (EFSE) process for the plant protein responsible for the companys Nitrogen Use Efficiency (NUE) trait
Tags: food
early
safety
administration
Apricus Biosciences Enrolls First Patients in Phase 2b Clinical Trial ...
2015-06-01 20:27:17| Biotech - Topix.net
Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has begun enrolling patients in a Phase 2b clinical trial to evaluate Apricus' novel product candidate, fispemifene, a selective estrogen receptor modulator , for the treatment of men with symptomatic secondary hypogonadism also known as low testosterone. The Phase 2 proof-of-concept clinical trial is a randomized, double-blind, placebo-controlled, parallel arm, multi-center study in approximately 160 hypogonadal men aged 18 to 64 who present with sexual dysfunction related to secondary hypogonadism, or low levels of testosterone.
Tags: trial
phase
patients
clinical
Dow AgroSciences, Arcadia Biosciences and Bioceres Collaborate to Develop and Commercialize Soybean Traits
2015-05-13 06:00:00| Corn & Soybean Digest
INDIANAPOLIS; DAVIS, Calif.; and ROSARIO, Argentina — April 28, 2015 — Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), Arcadia Biosciences, Inc., and Bioceres, S.A., announced today an agreement to develop and commercialize innovative traits in soybeans. read more
Tags: develop
dow
traits
collaborate
Dow AgroSciences, Arcadia Biosciences, Bioceres To Develop And Commercialize Soybean Traits
2015-05-04 14:03:31| Chemicals - Topix.net
DOW AGROSCIENCES, ARCADIA BIOSCIENCES, BIOCERES TO DEVELOP AND COMMERCIALIZE SOYBEAN TRAITS May 4, 2015 Source: Dow AgroSciences news release Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company , Arcadia Biosciences, Inc. and Bioceres, S.A. announced today an agreement to develop and commercialize innovative traits in soybeans. The collaboration leverages Dow AgroSciences' technology, regulatory expertise, and commercial seed capabilities with a leading soybean abiotic stress platform and unique grower relationships in South America represented by Verdeca LLC, a joint venture between Arcadia and Bioceres.
Tags: develop
dow
traits
arcadia
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »